Assembly Biosciences, Inc. (ASMB) vs YD Bio Limited (YDES)

Assembly Biosciences, Inc. and YD Bio Limited are both Biotechnology companies. Assembly Biosciences, Inc. and YD Bio Limited are of similar size ($479.1M and $476.8M).

Valuation

Metric ASMB YDES Biotechnology median
P/E 22.32 — 8.56
P/S 5.74 — 10.17
P/B 1.40 — 2.34
Price to free cash flow n/m — 20.42
EV/EBITDA n/m — 0.69
EV/Sales 1.46 — 9.64
Earnings yield 4.48% — (29.41%)
Free cash flow yield (8.98%) — (23.50%)

Profitability

Metric ASMB YDES Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (11.75%) — 0.00%
Net margin (0.06%) — 0.00%
Free cash flow margin (51.53%) — 0.00%
Return on equity (0.03%) — (56.66%)
Return on assets (0.02%) — (49.22%)
Return on invested capital 0.00% — 0.00%

Growth

Metric ASMB YDES Biotechnology median
Revenue growth (TTM) 125.12% — 5.64%
EPS growth (last fiscal year) 91.78% — 30.08%
Revenue growth, 5-year CAGR 35.27% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ASMB YDES Biotechnology median
Debt to equity 0.00 — 0.00
Current ratio 13.99 — 4.72
Net debt to EBITDA 17.31 — 0.96

Dividend

Metric ASMB YDES Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ASMB YDES Biotechnology median
Market cap 479.08m 476.77m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack